RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Apixaban

Reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation, Prophylaxis of deep vein thrombosis (DVT) following hip or knee replacement, Treatment of DVT and PE, Reduction in the risk of recurrent DVT and PE

Boxed warning

  • WARNING: (A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS (B) SPINAL/EPIDURAL HEMATOMA (A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS Premature discontinuation of any oral anticoagulant, including ELIQUIS, increases the risk of thrombotic events. If anticoagulation with ELIQUIS is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant [see Dosage and ... (see full label)

High-alert medication

  • Antithrombotic agents - DOACs (class)

Indications

  • Reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation
  • Prophylaxis of deep vein thrombosis (DVT) following hip or knee replacement
  • Treatment of DVT and PE
  • Reduction in the risk of recurrent DVT and PE

Adult dosing

  • afib initial: dose: 5; unit: mg; route: PO; interval: twice daily; fixed: true; labelExcerpt: The recommended dose of ELIQUIS for most patients is 5 mg taken orally twice daily.
  • afib reduced: dose: 2.5; unit: mg; route: PO; interval: twice daily; fixed: true; labelExcerpt: The recommended dose of ELIQUIS is 2.5 mg twice daily in patients with at least two of the following characteristics: age greater than or equal to 80 years body weight less than or equal to 60 kg serum creatinine greater than or equal to 1.5 mg/dL
  • dvt pe treatment: dose: 10; unit: mg; route: PO; interval: twice daily for 7 days, then 5 mg twice daily; fixed: true; labelExcerpt: The recommended dose of ELIQUIS is 10 mg taken orally twice daily for the first 7 days of therapy. After 7 days, the recommended dose is 5 mg taken orally twice daily.
  • prophylaxis dvt: dose: 2.5; unit: mg; route: PO; interval: twice daily; fixed: true; labelExcerpt: The recommended dose of ELIQUIS is 2.5 mg taken orally twice daily.

Pediatric dosing

  • Consult pharmacy/current label

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Not recommended in patients with severe hepatic impairment.

Contraindications

  • Active pathological bleeding
  • Severe hypersensitivity to ELIQUIS

Clinical pearls

  • Discontinue at least 48 hours prior to elective surgery with moderate/high bleeding risk.
  • Crushed tablets can be suspended in water, D5W, apple juice, or mixed with applesauce.
  • If a dose is missed, take as soon as possible on the same day; do not double the dose.
  • Monitor for signs of bleeding; agent to reverse anti-factor Xa activity is available.

Source and review

  • DailyMed label (apixaban, ELIQUIS), Set ID 41a133ef-e461-48ad-8221-b735bdd0ec25, effective 2026-09-24. Last reviewed: 2026-11-11